Fabian Streit

Apr 24, 2024 | nature.com | Dominic B. Dwyer |Sergi Papiol |Fabian Streit |Marcella Rietschel |Bertram Müller-Myhsok |Peter Falkai | +4 more

AbstractThe response variability to repetitive transcranial magnetic stimulation (rTMS) challenges the effective use of this treatment option in patients with schizophrenia. This variability may be deciphered by leveraging predictive information in structural MRI, clinical, sociodemographic, and genetic data using artificial intelligence. We developed and cross-validated rTMS response prediction models in patients with schizophrenia drawn from the multisite RESIS trial.